Matthew Siegel is vice president of medical affairs at Maine Behavioral Healthcare in Portland.
Matthew Siegel
Vice president
Maine Behavioral Healthcare
From this contributor
Autism can mask anxiety symptoms
Anxiety is one of the most common mental health conditions, as well as one of the most treatable. But when a person has autism, anxiety symptoms can be hard to see. Matthew Siegel calls for anxiety tests and treatments that are tailored to people with autism.
Searching for psychiatrists with expertise in autism
There is an urgent need for psychiatrists who are trained to care for individuals with autism. Matthew Siegel calls for a formal training program in autism for psychiatrists.
Searching for psychiatrists with expertise in autism
Explore more from The Transmitter
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.
Oregon primate research center to downsize monkey colony, pivot to non-animal models
The center’s host university had been negotiating with the federal government about converting the center into an animal sanctuary. A new plan, approved today, preserves some of the center’s nonhuman primate studies.
A planetarium for the brain
Tyler Sloan’s new film, more than a decade in the making, takes viewers on an immersive journey.
A planetarium for the brain
Tyler Sloan’s new film, more than a decade in the making, takes viewers on an immersive journey.
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.
Neuroscientists weigh in on White House proposal for ‘moonshot infrastructure’ for connectomics
A report from the Trump administration calls for a “new golden age” of science, in which the federal government supports mission-driven collaborations to deliver high returns on research investments.